Clinical Trial Update: Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating radiation therapy in combination with temozolomide and irinotecan for newly diagnosed glioblastoma multiforme. The trial statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• Camptosar (irinotecan)
• Temodar (Temozolomide)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Brain and Central Nervous System Tumors | Phase 2 | Status: COMPLETED